Additional information
White powder
139481-72-4
ACI-032124
184.1-186.9°C
C43H34N6O3
682.77
cold Condition
-20°C
Hypertension
Pharmaceutical Impurity Standards
2-Ethoxy-1-[[2`-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1`-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (N-Trityl candesartan)
2-Ethoxy-1-[(2?-(1-trityl-1H-tetrazol-5-yl)-1,1?-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid Candesartan-trityl candesartan
Candesartan-trityl candesartan





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)